MIAMI and TORONTO, March 31, 2025 /PRNewswire/ — Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) (“Sekur” or the “Company”), a leading Swiss hosted cybersecurity and privacy communications platform, is pleased to announce that further to its news releases dated August 26,…
Author: sHq_LoGiNz
Adjusted Revenues, Adjusted EBITDA and Adjusted Net Income: DeFi Technologies recorded Adjusted Revenues of C$42.6 million (approximately US$31.1 million) and C$204.4 million (approximately US$144.8 million – annual) for the three and twelve months period ended December 31, 2024 and…
Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p
VANCOUVER, BC, March 31, 2025 /PRNewswire/ – (TSX: NUAG) (NYSE American: NEWP) (“New Pacific” or the “Company”) announces that Andrew Williams will be stepping down as Chief Executive Officer (“CEO”) and Director of the company effective April 15. The Company also announces that it has…
TriPost’s Asset Solutions Strategy Completes Inaugural Secondary Market Transaction, Leveraging its Deep Track Record of Investing in Real Estate Operators NEW YORK, March 31, 2025 /PRNewswire/ — TriPost Capital Partners, LLC (“TriPost”), a real estate private equity firm focused on…
BTQ’s Dr. Gavin Brennen to Speak at Quantum Industry Day in Sydney: BTQ Technologies’ Chief Quantum Officer, Dr. Gavin Brennen, will join a fireside chat titled “Funding and Policy for Quantum Technologies” at Quantum Industry Day in Sydney, Australia, to discuss funding opportunities,…
Related amendments made to financing arrangements and management agreement NEW YORK, March 31, 2025 /PRNewswire/ — Star Holdings (NASDAQ: STHO) (the “Company”) announced the following: Share Repurchase Program The Company’s Board of Trustees has authorized the repurchase of up to $10…
Primary endpoint met, with TSND-201 demonstrating statistically significant placebo-adjusted CAPS-5 improvement of -9.64 points on Day 64 (p = 0.011) TSND-201 demonstrated rapid improvements, with a statistically significant placebo-adjusted CAPS-5 improvement of -8.00 points on Day 10 (p…
Kazia to receive USD $1 million from Vivesto for the intellectual property and trademark assets rights to the oncology drug candidate, Cantrixil SYDNEY, March 31, 2025 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or “the Company”), an oncology-focused drug…
METRO CHICAGO, Ill., March 31, 2025 /PRNewswire/ — John Koudounis, President and CEO of Calamos, announced the planned April launch of the three new ETFs in the World’s First Downside Protected Bitcoin ETF Suite, offering Bitcoin upside growth with 100% (CBOA), 90% (CBXA), and 80% (CBTA)…